Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

PIERRE GHOLAM

Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology

NPI
1477579647
CMS profile
490846
Location
CLEVELAND, OH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$179,436.77

230 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

By paying entity

PY2022 · entire year · sorted by reported total

Page 4 of 5; records 151–200 of 230 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

PIERRE GHOLAM

NPI 1477579647 · CMS profile ID 490846

Allopathic & Osteopathic Physicians / Internal Medicine / Gastroenterology

CLEVELAND, OH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 4 of 5; records 151–200 of 230 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1477579647?year=2022&recipient=provider&page=4#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
PIERRE GHOLAM, NPI 1477579647, CMS profile ID 490846. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 5; records 151–200 of 230 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1477579647?year=2022&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). PIERRE GHOLAM, NPI 1477579647, CMS profile ID 490846. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 5; records 151–200 of 230 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1477579647?year=2022&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
PIERRE GHOLAM, NPI 1477579647, CMS profile ID 490846, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 5; records 151–200 of 230 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1477579647?year=2022&recipient=provider&page=4#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

230 matching records · $179,436.77 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 230 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 151–200 of 230.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ABBVIE INC. $22.5206/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891025921 CMS
ABBVIE INC. $7.4906/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891025923 CMS
ABBVIE INC. $47.3106/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891025925 CMS
ABBVIE INC. $7.4906/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891025927 CMS
ABBVIE INC. $116.0006/11/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891025929 CMS
ABBVIE INC. $192.6606/10/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891025907 CMS
ABBVIE INC. $125.0006/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891025909 CMS
ABBVIE INC. $47.3606/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891025903 CMS
ABBVIE INC. $270.2706/08/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891025905 CMS
ABBVIE INC. $102.5806/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891025901 CMS
ABBVIE INC. $32.1906/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891025897 CMS
ABBVIE INC. $269.1006/06/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891025899 CMS
Exelixis Inc. $156.6206/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932463119 CMS
Genentech USA, Inc. $109.8806/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 950769157 CMS
Gilead Sciences, Inc. $3,000.0006/03/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929438215 CMS
Gilead Sciences, Inc. $92.9406/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929520141 CMS
ABBVIE INC. $10.3206/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891025895 CMS
EISAI INC. $16.6005/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908075409 CMS
EISAI INC. $32.6905/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908075413 CMS
EISAI INC. $33.9605/25/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908075417 CMS
EISAI INC. $40.0005/25/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908075421 CMS
Gilead Sciences, Inc. $22.2305/25/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929464021 CMS
ABBVIE INC. $3,500.0005/24/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891025893 CMS
EISAI INC. $3.2005/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908075385 CMS
EISAI INC. $3.5505/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908075389 CMS
EISAI INC. $26.9105/24/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908075393 CMS
EISAI INC. $35.9305/24/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908075397 CMS
EISAI INC. $49.5405/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908075401 CMS
EISAI INC. $76.0305/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908075405 CMS
ABBVIE INC. $3,500.0005/23/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891025891 CMS
ABBVIE INC. $63.3505/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891025889 CMS
Gilead Sciences, Inc. $3,000.0005/18/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929438221 CMS
Gilead Sciences, Inc. $120.8305/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929520147 CMS
EISAI INC. $2,580.0005/06/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908075381 CMS
Genentech USA, Inc. $2,580.0004/30/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 950668295 CMS
ABBVIE INC. $2,300.0004/29/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891025887 CMS
Gilead Sciences, Inc. $3,920.0004/29/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929446883 CMS
Gilead Sciences, Inc. $354.8204/29/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929464039 CMS
Gilead Sciences, Inc. $414.5004/29/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929464045 CMS
Gilead Sciences, Inc. $544.7004/29/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929464051 CMS
Gilead Sciences, Inc. $43.7504/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929520125 CMS
Gilead Sciences, Inc. $50.0004/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929520133 CMS
Gilead Sciences, Inc. $80.2604/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929520139 CMS
ABBVIE INC. $3,500.0004/11/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891025885 CMS
ABBVIE INC. $124.3404/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891025883 CMS
ABBVIE INC. $249.3104/04/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891025879 CMS
ABBVIE INC. $20.4804/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891025881 CMS
ABBVIE INC. $135.7203/31/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891025877 CMS
EISAI INC. $1,330.0003/31/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908075351 CMS
Gilead Sciences, Inc. $18.0103/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929520121 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $267,766.21 342
PY2020 $112,815.59 138
PY2021 $133,254.65 150
PY2022 $179,436.77 230
PY2023 $221,256.83 269
PY2024 $232,655.62 255
PY2025 $459,055.31 414

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $60,225.75 15
PY2023 Principal investigator $72,270.30 18
PY2022 Recipient $121.01 2
PY2022 Principal investigator $33,735.80 12
PY2021 Principal investigator $32,577.90 10
PY2020 Principal investigator $33,497.10 16
PY2019 Principal investigator $101,304.02 24

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

15 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Bausch Health US, LLC $1,500.00 05/06/2024 Covered Recipient Teaching Hospital
Rainbow Babies & Childrens Hospital
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis No dispute reported 06/30/2026 1151651188
Principal investigator 1 Intercept Pharma Europe Ltd. $9,775.75 03/27/2024 Covered Recipient Teaching Hospital
Rainbow Babies & Childrens Hospital
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE) No dispute reported 06/30/2026 1119227729
Principal investigator 1 Intercept Pharma Europe Ltd. $17,350.00 03/14/2024 Covered Recipient Teaching Hospital
Rainbow Babies & Childrens Hospital
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE) No dispute reported 06/30/2026 1119227723
Principal investigator 1 Intercept Pharma Europe Ltd. $500.00 03/14/2024 Covered Recipient Teaching Hospital
Rainbow Babies & Childrens Hospital
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE) No dispute reported 06/30/2026 1119227725
Principal investigator 1 Intercept Pharma Europe Ltd. $3,300.00 03/14/2024 Covered Recipient Teaching Hospital
Rainbow Babies & Childrens Hospital
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE) No dispute reported 06/30/2026 1119227727
Principal investigator 1 Bausch Health US, LLC $1,650.00 02/22/2024 Covered Recipient Teaching Hospital
Rainbow Babies & Childrens Hospital
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis No dispute reported 06/30/2026 1151651192
Principal investigator 1 Bausch Health US, LLC $1,000.00 02/22/2024 Covered Recipient Teaching Hospital
Rainbow Babies & Childrens Hospital
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis No dispute reported 06/30/2026 1151651197
Principal investigator 1 Bausch Health US, LLC $2,000.00 02/22/2024 Covered Recipient Teaching Hospital
Rainbow Babies & Childrens Hospital
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis No dispute reported 06/30/2026 1151651201
Principal investigator 1 Bausch Health US, LLC $800.00 02/22/2024 Covered Recipient Teaching Hospital
Rainbow Babies & Childrens Hospital
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis No dispute reported 06/30/2026 1151651206
Principal investigator 1 Bausch Health US, LLC $15,000.00 02/22/2024 Covered Recipient Teaching Hospital
Rainbow Babies & Childrens Hospital
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis No dispute reported 06/30/2026 1151651210
Principal investigator 1 Bausch Health US, LLC $2,000.00 02/22/2024 Covered Recipient Teaching Hospital
Rainbow Babies & Childrens Hospital
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis No dispute reported 06/30/2026 1151651215
Principal investigator 1 Bausch Health US, LLC $1,050.00 02/22/2024 Covered Recipient Teaching Hospital
Rainbow Babies & Childrens Hospital
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis No dispute reported 06/30/2026 1151651219
Principal investigator 1 Bausch Health US, LLC $1,500.00 02/22/2024 Covered Recipient Teaching Hospital
Rainbow Babies & Childrens Hospital
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis No dispute reported 06/30/2026 1151651223
Principal investigator 1 Bausch Health US, LLC $2,000.00 02/22/2024 Covered Recipient Teaching Hospital
Rainbow Babies & Childrens Hospital
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis No dispute reported 06/30/2026 1151651228
Principal investigator 1 Bausch Health US, LLC $800.00 02/22/2024 Covered Recipient Teaching Hospital
Rainbow Babies & Childrens Hospital
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis No dispute reported 06/30/2026 1151651232